Research ArticleArticle
Multimorbidity in Axial Spondyloarthropathy and Its Association with Disease Outcomes: Results from the Ankylosing Spondylitis Registry of Ireland Cohort
Gillian Fitzgerald, Phil Gallagher and Finbar D. O’Shea
The Journal of Rheumatology May 2019, jrheum.181415; DOI: https://doi.org/10.3899/jrheum.181415
Gillian Fitzgerald
From the Department of Rheumatology, St. James’s Hospital; Department of Clinical Medicine, Trinity College Dublin; Department of Rheumatology, St. Vincent’s University Hospital, Dublin, Ireland.
The Ankylosing Spondylitis Registry of Ireland (ASRI) is supported by an unrestricted grant from Pfizer Pharmaceuticals and AbbVie Pharmaceuticals. GF is a recipient of the Bresnihan-Molloy Scholarship from the Royal College of Physicians of Ireland, funded by AbbVie. The funders had no role in the design of the study, collection of the data, analysis, and interpretation of the data, or any part of manuscript preparation.
G. Fitzgerald, MB BCh, BAO, MRCPI, Rheumatologist, PhD candidate, Department of Rheumatology, St. James’s Hospital, and Department of Clinical Medicine, Trinity College Dublin; P. Gallagher, RGN, Department of Rheumatology, St. Vincent’s University Hospital; F.D. O’Shea, MB BCh, BAO, MRCPI, Consultant Rheumatologist, General Physician, Department of Rheumatology, St. James’s Hospital, and Department of Clinical Medicine, Trinity College Dublin.
Address correspondence to Dr. G. Fitzgerald, Department of Rheumatology, St. James’s Hospital, Dublin, Ireland. E-mail: gifitzge@tcd.ie
Accepted for publication May 6, 2019.
Phil Gallagher
From the Department of Rheumatology, St. James’s Hospital; Department of Clinical Medicine, Trinity College Dublin; Department of Rheumatology, St. Vincent’s University Hospital, Dublin, Ireland.
The Ankylosing Spondylitis Registry of Ireland (ASRI) is supported by an unrestricted grant from Pfizer Pharmaceuticals and AbbVie Pharmaceuticals. GF is a recipient of the Bresnihan-Molloy Scholarship from the Royal College of Physicians of Ireland, funded by AbbVie. The funders had no role in the design of the study, collection of the data, analysis, and interpretation of the data, or any part of manuscript preparation.
G. Fitzgerald, MB BCh, BAO, MRCPI, Rheumatologist, PhD candidate, Department of Rheumatology, St. James’s Hospital, and Department of Clinical Medicine, Trinity College Dublin; P. Gallagher, RGN, Department of Rheumatology, St. Vincent’s University Hospital; F.D. O’Shea, MB BCh, BAO, MRCPI, Consultant Rheumatologist, General Physician, Department of Rheumatology, St. James’s Hospital, and Department of Clinical Medicine, Trinity College Dublin.
Address correspondence to Dr. G. Fitzgerald, Department of Rheumatology, St. James’s Hospital, Dublin, Ireland. E-mail: gifitzge@tcd.ie
Accepted for publication May 6, 2019.
Finbar D. O’Shea
From the Department of Rheumatology, St. James’s Hospital; Department of Clinical Medicine, Trinity College Dublin; Department of Rheumatology, St. Vincent’s University Hospital, Dublin, Ireland.
The Ankylosing Spondylitis Registry of Ireland (ASRI) is supported by an unrestricted grant from Pfizer Pharmaceuticals and AbbVie Pharmaceuticals. GF is a recipient of the Bresnihan-Molloy Scholarship from the Royal College of Physicians of Ireland, funded by AbbVie. The funders had no role in the design of the study, collection of the data, analysis, and interpretation of the data, or any part of manuscript preparation.
G. Fitzgerald, MB BCh, BAO, MRCPI, Rheumatologist, PhD candidate, Department of Rheumatology, St. James’s Hospital, and Department of Clinical Medicine, Trinity College Dublin; P. Gallagher, RGN, Department of Rheumatology, St. Vincent’s University Hospital; F.D. O’Shea, MB BCh, BAO, MRCPI, Consultant Rheumatologist, General Physician, Department of Rheumatology, St. James’s Hospital, and Department of Clinical Medicine, Trinity College Dublin.
Address correspondence to Dr. G. Fitzgerald, Department of Rheumatology, St. James’s Hospital, Dublin, Ireland. E-mail: gifitzge@tcd.ie
Accepted for publication May 6, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Multimorbidity in Axial Spondyloarthropathy and Its Association with Disease Outcomes: Results from the Ankylosing Spondylitis Registry of Ireland Cohort
Gillian Fitzgerald, Phil Gallagher, Finbar D. O’Shea
The Journal of Rheumatology May 2019, jrheum.181415; DOI: 10.3899/jrheum.181415